Literature DB >> 29689199

Arginine Methylation by PRMT2 Controls the Functions of the Actin Nucleator Cobl.

Wenya Hou1, Sabine Nemitz1, Simone Schopper2, Michael Lund Nielsen2, Michael Manfred Kessels3, Britta Qualmann4.   

Abstract

The complex architecture of neuronal networks in the brain requires tight control of the actin cytoskeleton. The actin nucleator Cobl is critical for neuronal morphogenesis. Here we reveal that Cobl is controlled by arginine methylation. Coprecipitations, coimmunoprecipitations, cellular reconstitutions, and in vitro reconstitutions demonstrated that Cobl associates with the protein arginine methyltransferase PRMT2 in a Src Homology 3 (SH3) domain-dependent manner and that this promotes methylation of Cobl's actin nucleating C-terminal domain. Consistently, PRMT2 phenocopied Cobl functions in both gain- and loss-of-function studies. Both PRMT2- and Cobl-promoted dendritogenesis relied on methylation. PRMT2 effects require both its catalytic domain and SH3 domain. Cobl-mediated dendritic arborization required PRMT2, complex formation with PRMT2, and PRMT2's catalytic activity. Mechanistic studies reveal that Cobl methylation is key for Cobl actin binding. Therefore, arginine methylation is a regulatory mechanism reaching beyond controlling nuclear processes. It also controls a major, cytosolic, cytoskeletal component shaping neuronal cells.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cordon bleu; PRMT2 interaction partner and substrate; WH2 domain; actin nucleation; arginine methylation; arginine methyltransferase; dendritogenesis; neuronal network formation; posttranslational modification

Mesh:

Substances:

Year:  2018        PMID: 29689199     DOI: 10.1016/j.devcel.2018.03.007

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  8 in total

1.  Liver disease-associated keratin 8 and 18 mutations modulate keratin acetylation and methylation.

Authors:  Kwi-Hoon Jang; Han-Na Yoon; Jongeun Lee; Hayan Yi; Sang-Yoon Park; So-Young Lee; Younglan Lim; Hyoung-Joo Lee; Jin-Won Cho; Young-Ki Paik; Williams S Hancock; Nam-On Ku
Journal:  FASEB J       Date:  2019-06-14       Impact factor: 5.191

Review 2.  Relationship between protein arginine methyltransferase and cardiovascular disease (Review).

Authors:  Sisi Zheng; Congcong Zeng; Ailing Huang; Fuqi Huang; Anna Meng; Zhuan Wu; Shouhong Zhou
Journal:  Biomed Rep       Date:  2022-09-16

Review 3.  Arginine Methylation in Brain Tumors: Tumor Biology and Therapeutic Strategies.

Authors:  Jean-Paul Bryant; John Heiss; Yeshavanth Kumar Banasavadi-Siddegowda
Journal:  Cells       Date:  2021-01-11       Impact factor: 6.600

4.  Poststroke dendritic arbor regrowth requires the actin nucleator Cobl.

Authors:  Yuanyuan Ji; Dennis Koch; Jule González Delgado; Madlen Günther; Otto W Witte; Michael M Kessels; Christiane Frahm; Britta Qualmann
Journal:  PLoS Biol       Date:  2021-12-13       Impact factor: 8.029

Review 5.  Remodeling the epigenome and (epi)cytoskeleton: a new paradigm for co-regulation by methylation.

Authors:  Cheryl Walker; Warren Burggren
Journal:  J Exp Biol       Date:  2020-07-03       Impact factor: 3.312

Review 6.  The Role of Protein Arginine Methylation as Post-Translational Modification on Actin Cytoskeletal Components in Neuronal Structure and Function.

Authors:  Britta Qualmann; Michael M Kessels
Journal:  Cells       Date:  2021-05-01       Impact factor: 6.600

7.  Arginine in C9ORF72 Dipolypeptides Mediates Promiscuous Proteome Binding and Multiple Modes of Toxicity.

Authors:  Mona Radwan; Ching-Seng Ang; Angelique R Ormsby; Dezerae Cox; James C Daly; Gavin E Reid; Danny M Hatters
Journal:  Mol Cell Proteomics       Date:  2020-02-21       Impact factor: 5.911

8.  Integrated Analysis Reveals ENDOU as a Biomarker in Head and Neck Squamous Cell Carcinoma Progression.

Authors:  Chengzhi Xu; Yunbin Zhang; Yupeng Shen; Yong Shi; Ming Zhang; Liang Zhou
Journal:  Front Oncol       Date:  2021-02-05       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.